Editorial: New treatment strategies in schizophrenia beyond dopamine: glutamatergic neurotransmission and more

Curr Pharm Biotechnol. 2012 Jun;13(8):1474-5. doi: 10.2174/138920112800784871.
No abstract available

Publication types

  • Editorial
  • Introductory Journal Article

MeSH terms

  • Antipsychotic Agents / therapeutic use
  • Dopamine
  • Receptors, Glutamate / physiology*
  • Schizophrenia / physiopathology
  • Schizophrenia / therapy*
  • Synaptic Transmission

Substances

  • Antipsychotic Agents
  • Receptors, Glutamate
  • Dopamine